Executive Search
Non-executive Search
Management Due Diligence
Market Mapping
Remuneration Benchmarking
Psychometric and Ability Testing
Executive and Non-executive Education
Built Environment and Support Services
Consumer
Energy Transition
Engineering and Manufacturing
Financial Services
Private Equity and Venture Capital
Professional Services
Public Sector and Not For Profit
Technology and Life Sciences
Chair and Non-Executive Director
CEO
CFO and Financial Management
Operations and General Management
Commercial
Human Resources
IT, Digital and Technology
Manufacturing, Supply Chain and Logistics
Legal and GovernanceContact the team at FWB to discuss your individual or company requirements, or to discover more about our specialist services.
FWB/Scottish Lifesciences Association – Drug Development Discussion Dinner
3 June 2013
- Uncategorized
This dinner has been arranged primarily to hear from Professor Claude Wischik, Executive Chairman and Co-Founder of TauRx Therapeutics. TauRx is possibly one of Scotland’s best kept secrets in terms of recent drug development activity. They are incorporated in Singapore with primary research and operations functions in Aberdeen. The company is focused on the development of novel treatments for Alzheimer’s disease and other Neurodegenerative diseases.
The TauRx story is an extraordinary one and we are looking forward to hearing not just about the scientific progress but also about the funding successes and challenges along the way and about the future for TauRx.
